top of page
Modern Architecture

Companies We've Partnered With

A selection of advisory, capital raising and venture building mandates completed by the D4 Bioventures team across life sciences, biomedical and healthcare.

GOVERMENT

UNIVERSITY & MRI

master_web.png

Chris O'Brien

Lifehouse

Advisor on commercialisation strategy, individual projects, and development of a commercialisation framework.

unsw-sydney.png

UNSW — School of
Biomedical Sciences

Advised on commercialisation strategy, including full review and triage of projects within the School.

image-removebg-preview (3).png

Garvan Institute of Medical Research

Acted as Garvan Venture Studio, incubating and advising commercialisation-ready projects toward investible start-up ventures.

lgo2.png

QIMR Berghofer Medical
Research Institute

Advised on commercialisation strategy, including deep review and gap analysis for a prospective spin-out opportunity.

CORPORATE

lgo3.png

Lucid Health Consulting

Advised on acquisition by IQVIA and supported Australian healthcare consulting firms on strategy, market access, and commercialisation.

lgo5.png

VenstraMedical

Advised on capital raising for a US medical device company developing a next-generation catheter-based heart pump.

lgo4.png

Macuject

Advised on capital raising, including Singapore-based VC introductions, supporting investment for its AI-powered clinical decision support.

lgo6.png

MammBio

Advised on capital raising for an animal health company developing a novel solution to treat bovine mastitis.

lgo8.png

Sequin Standards

Led the Garvan spin-off and successful institutional raise, providing controls-as-a-service integrating synthetic DNA and bioinformatics.

lgo12.png

Brain Vector

Advised on commercial strategy and clinical collaborator introductions for AI and VR neurotech solutions improving mental health.

lgo9.png

SanguiBio

Advised on investment readiness for an at-home blood diagnostic detecting early pre-cancerous polyps in the colon.

lgo13.png

WeLysn

Advised on capital raising for a digital health provider of mental health and cancer support solutions.

lgo14png.png

23Strands

Advised on capital raising and business development for an Australian genomics and AI company delivering personalised healthcare.

lgo15.png

ResusRight

Advised on commercialisation, including trade sale and licensing, for a neonatal resuscitation medtech company.

APAC

lgo16.png

Life Biosciences

lgo18.png

Minerva Biotechnologies

lgo17.png

Antabio

lgo19.png

Porcine Therapeutics

Why Teams Choose to Work with D4 Bioventures

Domain Expertise

Deep experience across biotech, medtech, diagnostics, and digital health, from technical assessment to commercial strategy.​

Investor Lens

We shape opportunities around the questions that investors, partners and acquirers will test.​​

​

​

Capital Access

We connect companies with relevant institutional, family office, HNWI and strategic investors across Australia and APAC, including Singapore and Hong Kong.

Deal Judgement

We understand how strategic value, risk, timing and negotiation shape successful transactions.

​

​

Outcome Focused

We focus on practical steps that add value by moving opportunities towards investment, partnering, licensing or exit.

​

Let’s Start the Conversation

Get in touch to discuss your opportunity and the right next step.

D4 Bioventures horizontal logo

SWG Capital Pty Ltd, (ABN 37 135 455 864) as a Corporate Authorised Representative (CAR No. 001296052) of FB Corp Pty Ltd, (ABN 16 675 876 490) (AFSL No. 557810)

The information in this website (the Information) has been prepared by SWG Capital. This information is for general information only and is not an offer for the purchase or sale of any financial product or services. The Information has been prepared for investors who qualify as wholesale clients under section 761G of the Corporations Act 2001 (Cth) (Corporations Act) or to any other person who is not required to be given a regulated disclosure document under the Corporations Act. The Information is not intended to provide you with financial or tax advice and does not take into account your objectives, financial situation or needs. Although we believe that the Information is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given the Licensee, SWG Capital or any other person. To the maximum extent possible, the Licensee, SWG Capital or any other person do not accept any liability for any statement in this Information.

© 2026 D4 Bioventures. All Rights Reserved.

Privacy Policy

bottom of page